ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag age related macular degeneration microbiology

Stem Cell Trial for Eye Disease Commences
Jef Akst | Sep 12, 2014 | 2 min read
Researchers at the RIKEN Center for Developmental Biology will treat the first patient in its clinical trial testing an induced pluripotent stem cell-based treatment for age-related macular degeneration.
Quasi-Lymphatic System in the Rodent Eye Clears Waste
Abby Olena, PhD | Apr 16, 2020 | 3 min read
Two rodent models of glaucoma have defects in the waste drainage system.
A Complement Renaissance
M. Kathryn Liszewski and John P. Atkinson | Jul 1, 2006 | 3 min read
FEATUREComplement A Complement Renaissance BY M. KATHRYN LISZEWSKI AND JOHN P. ATKINSONARTICLE EXTRASRelated Article:A Complementary PathwayHow one group of researchers brought a scientific idea to the clinic for a rare diseaseInfographics: Interrupting ComplementPaths to MarketWeb Extra:Margarita Soto: A life with PNHMore than 600 million years ago, primitive components of the complement system lik
In Situ Antibodies
Jyoti Madhusoodanan | Feb 2, 2016 | 4 min read
Compared with systemic injections, localized antibody therapies may be more effective for some indications.
Antibody Alternatives
Paul Ko Ferrigno and Jane McLeod | Feb 1, 2016 | 10+ min read
Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.
A Practical Guide to the HapMap
Aileen Constans | Feb 1, 2006 | 5 min read
Here are five tips to getting the most out of your next gene-association study
Banking on iPSCs
Kerry Grens | Sep 1, 2014 | 5 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Banking on iPSCs
Kerry Grens | Jun 29, 2014 | 6 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Aptamers Identify Protein Signatures
Ricki Lewis | Apr 1, 2001 | 3 min read
Graphic: Leza BerardoneA technique not deemed "sexy" enough for commercialization a decade ago may finally find its niche in proteomics. SomaLogic Inc. of Boulder, Colo. is pioneering aptamers, which are modified DNA molecules that bind specific proteins in body fluid samples. Aptamers are initially selected for specific binding activities from a huge starting pool, then variants are obtained during subsequent rounds of amplification. The technology builds on the ability of aptamers to bind tena
Welch Foundation Gives $250,000 Award To HHMI's Krebs And NHLBI's Stadtman
Barbara Spector | Nov 10, 1991 | 5 min read
November 11, 1991 HHMI's Krebs And NHLBI's Stadtman Welch Foundation Gives $250,000 Award To HHMI's Krebs And NHLBI's Stadtman The Houston-based Robert A. Welch Foundation has named Edwin G. Krebs and Earl Reece Stadtman corecipients of the 1991 Robert A. Welch Award. Krebs is a senior investigator of the Howard Hughes Medical Institute and a professor in the department of pharmacology at the University of Washington in Seattle. Stadtman is the chief of the laboratory of biochemistry at t

Run a Search

ADVERTISEMENT